Replies to post #226 on Vanda Pharmaceuticals, Inc. (VNDA)

[juxtaposezen]

As did I today. Phase III data coming on Tasimelteon, cash rich no debt. I had an alert set to remind me to pick some up if it dropped which triggered today:

The following Stock Alert has been triggered:

VANDA PHARMACEUTICALS INC - Sale price dropped to 3.0200
Last Sale: 3.02 at 10:40:29
Price when alert was set: 3.21 on 12/07/12 09:04:51 EST

Current Quote for VNDA
Last: 3.02
Change: -0.12 (-3.82 %)
High: 3.14
Low: 3.02
Annual High: 5.47
Annual Low: 2.92
Previous Close: 3.14
Volume: 897293
100-Day Avg. Volume: 131661
200-Day Moving Avg: 4.16

DJIA: 13257.04 (+8.6)
NASDAQ: 3022.57 (+0.27)
S&P500: 1429.73 (+1.89)

[surf1944]

1:30AM Vanda Pharma receives negative opinion from CHMP on Fanaptum for the treatment of schizophrenia (VNDA) 3.22 : Co announces that the European Medicines Agency's Committee for Medicinal Product for Human Use has issued a negative opinion recommending against approval of Fanaptum for the treatment of schizophrenia in adult patients in the European Union. The CHMP was of the opinion that the benefits of Fanaptum did not outweigh its risks and recommended against marketing authorization at this point in time. Vanda intends to appeal this opinion and request a re-examination of the decision by the CHMP.

[juxtaposezen]

Vanda Announces Positive Phase III Results For Tasimelteon In The Treatment Of Non-24-Hour Disorder

http://ih.advfn.com/p.php?pid=nmona&article=55506759&symbol=VNDA